Wegovy Shortage Updates in 2026

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

Wegovy dosing starts low and increases slowly to reduce side effects, as updated in December 2025.
Common Ozempic side effects, like abdominal pain and nausea, often improve after 3 months.
In one 2-year study, 3% of Ozempic injection users experienced vision complications compared to 1.8% taking a placebo.
Wegovy and similar medicines caused thyroid tumors in rodent studies, but it is not known if this applies to people.

GLP-1 medications like Wegovy and Ozempic help with weight loss and managing type 2 diabetes, but users should understand how they work and their possible effects. The dosing for Wegovy, for instance, starts low and increases slowly to help the body adjust and lessen side effects. This approach was updated in December 2025 to make treatment smoother. While many side effects are mild and temporary, such as the abdominal pain and nausea that often improve for Ozempic users after 3 months, some long-term issues can occur. These can include problems like pancreatitis, kidney injury, and vision changes. In one 2-year study, 3% of Ozempic injection users faced vision complications, which was higher than the 1.8% in the placebo group. It's also important to know that in studies with rodents, Wegovy and similar medicines led to thyroid tumors, including cancer, though it is not yet known if this risk extends to humans.

What Are the Most Common Side Effects of Wegovy and Ozempic?

Most people who start GLP-1 medications like Ozempic or Wegovy will experience some side effects. These are typically mild to moderate and often get better as the body adjusts to the medication. The most commonly reported side effects include abdominal pain or discomfort, a loss of appetite, indigestion or heartburn, and reactions at the injection site like redness, swelling, or itching Long-Term Side Effects of Ozempic. These symptoms are most likely to show up when someone first starts Ozempic or after their dose is increased. For most individuals, these initial side effects tend to improve significantly after about 3 months of treatment.

Common Gastrointestinal Issues

Gastrointestinal issues are among the most frequently reported side effects. Users might experience nausea, vomiting, diarrhea, or abdominal pain. These symptoms can sometimes be severe enough to cause dehydration or even malnutrition if they are not managed properly. The body needs time to get used to the way these medications work, which is why a gradual increase in dosage is often recommended. When we look at how people report these issues, they often happen in the first few weeks. As the body adapts, the severity and frequency of these symptoms usually go down.

Many people find that simple adjustments can help. Eating smaller meals, avoiding fatty foods, and staying hydrated are common strategies. However, if these symptoms persist or become severe, it is important to talk to a healthcare provider. They can help determine if a dose adjustment is needed or if other strategies should be considered. Understanding that these are common and often temporary can help patients manage their expectations and stick with their treatment plan. The goal is to minimize discomfort while still getting the benefits of the medication.

Injection Site Reactions

Beyond digestive issues, some people may notice reactions where they inject the medication. These reactions can include redness, swelling, or itching. They are usually mild and tend to resolve on their own. It is a good practice to rotate injection sites to prevent irritation in one area. If an injection site reaction becomes very painful, spreads, or shows signs of infection, a healthcare provider should be contacted. These reactions are generally not a reason to stop treatment, but they should be monitored.

The body's initial response to the medication can sometimes be seen at the injection site. This is a normal part of how the immune system reacts to anything introduced under the skin. Over time, as the body gets used to the medication, these reactions typically become less common or severe. Keeping the injection area clean and following proper injection techniques can also help reduce the chance of these reactions occurring. Most people find that any mild discomfort at the injection site is manageable and temporary.

Appetite Changes and Indigestion

A loss of appetite is another common side effect, which for many, is part of how these medications help with weight loss. However, sometimes this can be too much, leading to not eating enough. Indigestion or heartburn can also occur, making meals uncomfortable. These symptoms are linked to how GLP-1 medications slow down the digestive process. This slower movement of food through the stomach can lead to feelings of fullness, bloating, and indigestion.

Managing these appetite changes often involves careful meal planning. Eating nutrient-dense foods, even in smaller amounts, can help ensure adequate nutrition. For indigestion or heartburn, over-the-counter remedies might offer relief, but discussing these with a doctor is always best. Understanding that these effects are part of the medication's mechanism of action can help patients navigate them. The aim is to achieve the desired therapeutic effect without causing significant discomfort or nutritional deficiencies.

Can Wegovy and Ozempic Cause Long-Term Complications?

Yes, Ozempic has been linked to certain long-term side effects that might last for months or even years after someone stops taking the medication. While many initial side effects are temporary, some problems can persist or develop over a longer period. Rare but serious long-term side effects can include pancreatitis, issues with the gallbladder, kidney problems, and changes in vision. Rapid weight loss from Ozempic can also lead to changes in body composition, which people sometimes describe as “Ozempic face” or “Ozempic body.”

Documented Long-Term Effects

Clinical trials have studied Ozempic for varying lengths to understand its effects. For instance, it was studied for 30 weeks for type 2 diabetes, for 104 weeks for cardiovascular outcomes in the SUSTAIN trials, and for 41 months in adults who had type 2 diabetes and chronic kidney disease. These long study periods help us understand what might happen over time. Drugs.com states, "Ozempic has the potential to cause certain long-term problems that may last months or years after stopping it. Some examples of long-term side effects you may experience from Ozempic include pancreatitis, vision problems, kidney injury, and skin changes (e.g., Ozempic face)."

It is important to review the full product information and talk with a healthcare provider about any potential risks. While some of these effects are rare, knowing about them helps patients make informed decisions. The goal is to weigh the benefits of the medication against these potential long-term risks. Ongoing monitoring by a doctor is crucial for anyone taking these medications for an extended period. This allows for early detection and management of any emerging issues.

Body Composition Changes

When someone loses weight very quickly, as can happen with GLP-1 medications, it can affect their body composition in ways that are noticeable. The terms "Ozempic face" or "Ozempic body" refer to these changes. Rapid fat loss can lead to a reduction in volume in the face, making it appear gaunt or older. Similarly, overall body fat reduction can change how a person's body looks, sometimes leading to loose skin or a different distribution of fat and muscle.

These changes are not direct side effects of the medication on the skin or tissues themselves, but rather a consequence of significant and quick weight loss. It is similar to what can happen with other methods of rapid weight reduction. While some people welcome these changes, others might find them aesthetically undesirable. Discussing these potential body composition changes with a healthcare provider can help set realistic expectations and explore strategies to manage them, such as focusing on muscle mass retention through exercise.

Kidney and Gallbladder Concerns

Kidney damage and a loss of kidney function are also potential long-term concerns with Ozempic. While the medication may help protect kidney health in people with type 2 diabetes or obesity, in some cases, kidney injury has been reported. It is vital for patients, especially those with pre-existing kidney conditions, to have their kidney function monitored regularly while on these medications. Any changes in kidney health should be promptly reported to a doctor.

Gallbladder disease and related complications are another rare but serious long-term effect. These can include gallstones or inflammation of the gallbladder (cholecystitis). The exact mechanism by which GLP-1 medications might contribute to gallbladder issues is still being studied, but it's thought to be related to rapid weight loss itself, which can increase the risk of gallstone formation. Symptoms of gallbladder problems might include severe pain in the upper right abdomen, nausea, vomiting, or fever. If these symptoms occur, medical attention is needed right away.

Is There a Risk of Pancreatitis with GLP-1 Medications?

Pancreatitis, which is an inflammation of the pancreas, has been reported by some people taking Ozempic during clinical trials, although it is considered rare. It remains unclear if Ozempic directly causes pancreatitis. This condition can be serious and involves severe upper stomach pain that might spread to the back, along with nausea, vomiting, and a rapid heartbeat. Pancreatitis usually resolves within two weeks, but it can sometimes last longer, and there was one report of chronic pancreatitis in a patient during Ozempic clinical trials.

Conflicting Evidence on Pancreatitis Risk

The link between Ozempic and pancreatitis has been a topic of study, with some findings showing no clear association. For example, in one 2-year study, 8 people taking injectable Ozempic experienced pancreatitis, compared to 10 people who were taking a placebo, which contained no active medication. This suggests that the incidence was actually slightly lower in the Ozempic group in that specific study. In other pooled studies involving oral semaglutide, 6 people reported pancreatitis, while only 1 person in the comparator group did. These numbers indicate a low but present occurrence.

However, a more recent and larger meta-analysis, which included about 35,000 patients, found that semaglutide is not associated with a higher risk of pancreatitis when compared to a placebo. This larger study suggests that while cases of pancreatitis are reported, they might not be directly caused by the medication at a higher rate than in the general population or those on placebo. Despite these findings, healthcare providers still advise patients to watch for signs and symptoms of pancreatitis because cases continue to be reported among people taking the medication.

Recognizing Symptoms of Pancreatitis

It is crucial for anyone taking GLP-1 medications to know the warning signs of pancreatitis. The most common symptom is severe pain in the upper stomach area, which can often radiate to the back. This pain can be constant and intense. Other symptoms include nausea, vomiting, and a rapid heartbeat. If you experience any of these symptoms, especially severe abdominal pain, you should seek medical attention immediately. Early diagnosis and treatment are important for managing pancreatitis effectively.

Pancreatitis can range from mild to severe. While most cases are acute and resolve within a couple of weeks, some individuals can develop chronic pancreatitis, which means the inflammation lasts for a longer time or recurs. The pancreas plays a vital role in digestion and blood sugar regulation, so its inflammation can have significant health implications. Even with the ongoing research suggesting no increased risk from semaglutide, vigilance for these symptoms remains a key part of patient care.

The Role of Medical Monitoring

Given the potential for pancreatitis, even if rare, regular medical monitoring is an important part of treatment with GLP-1 medications. Healthcare providers will often discuss the risks and symptoms with patients before starting the medication. They will also assess a patient's medical history for any pre-existing conditions that might increase their risk of pancreatitis. This proactive approach helps to ensure patient safety and allows for prompt intervention if any serious side effects arise.

Patients should feel comfortable discussing any new or worsening symptoms with their doctor. It is a shared responsibility between the patient and the healthcare team to monitor for potential complications. While the evidence on pancreatitis and semaglutide continues to evolve, staying informed and vigilant is the best course of action. The overall benefits of these medications for diabetes and weight management are often significant, making careful risk assessment and management essential.

How Do GLP-1 Medications Affect Vision?

Ozempic may worsen an existing eye condition called diabetic retinopathy, especially when blood sugar levels improve very rapidly. Diabetic retinopathy is a complication of diabetes that affects the eyes, and quick changes in blood sugar can sometimes make it worse temporarily. Vision problems are listed among the potential long-term effects of Ozempic. Beyond diabetic retinopathy, Ozempic might also cause a condition called non-arteritic anterior ischemic optic neuropathy (NAION), which occurs when the optic nerve does not receive enough blood supply.

Impact on Diabetic Retinopathy

For individuals with diabetes, maintaining stable blood sugar levels is crucial for eye health. When blood sugar levels drop too quickly, as can happen when starting or increasing the dose of Ozempic, it can sometimes stress the blood vessels in the eyes. This stress can lead to a temporary worsening of diabetic retinopathy. In a 2-year study, 3% of Ozempic injection users experienced complications related to diabetic retinopathy, compared to 1.8% of those taking a placebo. This difference suggests a potential, though small, increase in risk.

In pooled studies that included both placebo and active-controlled trials, 4.2% of oral semaglutide users reported diabetic retinopathy, compared to 3.8% in the comparator group. This data indicates that while the risk is present, it is not dramatically higher. Patients with pre-existing diabetic retinopathy should be closely monitored by an eye specialist when starting or adjusting GLP-1 medications. Regular eye exams are important to catch any changes early and manage them effectively.

Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)

NAION is a serious eye condition that can lead to sudden, painless vision loss. It happens when there isn't enough blood flow to the optic nerve, which transmits visual information from the eye to the brain. While Ozempic might cause NAION, it is considered a rare occurrence. Symptoms of NAION include sudden blurring or loss of vision in one eye, often noticed upon waking. If any sudden changes in vision occur, it is critical to seek immediate medical attention.

The optic nerve needs a constant supply of blood to function correctly. Any disruption to this blood flow can have lasting effects on vision. The exact link between GLP-1 medications and NAION is still being explored, but it is important for patients and doctors to be aware of this potential risk. Patients with a history of vision problems or risk factors for NAION should discuss these concerns with their healthcare provider before starting Ozempic or similar medications.

Importance of Eye Monitoring

Given these potential vision-related side effects, regular eye check-ups are especially important for individuals taking GLP-1 medications, particularly those with diabetes. An eye doctor can monitor for any signs of worsening diabetic retinopathy or other eye conditions. Early detection of any vision problems can allow for timely intervention and potentially prevent more severe or permanent vision loss. Patients should report any changes in their vision, no matter how minor, to their healthcare provider.

The benefits of GLP-1 medications in managing diabetes and weight are significant, but these must be balanced against potential risks. Comprehensive care includes not just managing the primary conditions but also monitoring for and addressing any side effects, including those affecting the eyes. This holistic approach ensures that patients receive the safest and most effective treatment possible.

What Other Serious Long-Term Effects Have Been Reported?

Beyond pancreatitis and vision problems, other rare but serious long-term effects have been reported with GLP-1 medications like Ozempic. These include gastrointestinal complications such as stomach paralysis (gastroparesis) and intestinal blockage. Kidney damage and a loss of kidney function are also potential concerns. Furthermore, there is a risk of thyroid tumors, including cancer, associated with Wegovy and similar medications, as observed in animal studies.

Gastrointestinal Complications: Stomach Paralysis and Intestinal Blockage

While common gastrointestinal side effects like nausea and diarrhea often improve, some individuals may experience more severe issues over time. Stomach paralysis, or gastroparesis, is a condition where the stomach muscles do not function properly, slowing down the movement of food to the small intestine. This can lead to persistent nausea, vomiting, bloating, and early fullness. Intestinal blockage is another serious, though rare, complication where food or stool cannot pass through the intestines. Both conditions can be very uncomfortable and may require medical intervention.

These severe gastrointestinal issues highlight the importance of careful monitoring, especially for patients who experience ongoing or worsening digestive symptoms. If symptoms like severe, persistent vomiting, abdominal distension, or inability to pass gas or stool occur, immediate medical attention is necessary. While these complications are rare, they underscore the need for patients to be vigilant and communicate openly with their healthcare providers about any unusual or severe symptoms.

Kidney Damage and Function Loss

Ozempic may help protect heart and kidney health in people with type 2 diabetes or obesity. However, kidney damage and a loss of kidney function have been identified as potential long-term side effects in some individuals. This means that while the medication can be beneficial for many, it can also pose a risk to kidney health for a small number of users. It is essential for patients, particularly those with pre-existing kidney disease or other risk factors for kidney problems, to have their kidney function monitored regularly while on these medications.

Symptoms of kidney problems can include swelling in the legs, ankles, or feet, changes in urination patterns, fatigue, and nausea. Any new or worsening symptoms that might suggest kidney issues should be reported to a healthcare provider promptly. Regular blood tests to check kidney function are a standard part of care for patients taking GLP-1 medications, helping to ensure that any potential issues are detected and addressed early.

Risk of Thyroid Tumors, Including Cancer

One of the most important safety warnings for Wegovy and other GLP-1 receptor agonists concerns the potential for thyroid tumors, including cancer. The Wegovy Important Safety Information states, "Wegovy® and other medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people." This warning is based on studies conducted in rodents, where these medications led to the development of thyroid tumors.

Because of this potential risk, people should tell their healthcare provider if they notice a lump or swelling in their neck, experience hoarseness, have trouble swallowing, or feel short of breath. These could be signs of thyroid cancer. It is crucial not to use Wegovy if you or any family member has ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition known as Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). This pre-screening helps to identify individuals who may be at a higher risk.

Other Potential Long-Term Effects

Beyond these specific concerns, other rare long-term effects mentioned in the research include gallbladder disease and potential mental health effects. Gallbladder issues, such as gallstones or inflammation, can arise, sometimes linked to rapid weight loss. While mental health effects are listed, specific details about them are not provided in the research. It is always important for patients to discuss any new or concerning symptoms, whether physical or mental, with their healthcare provider to ensure comprehensive care.

How Is Wegovy Dosed to Minimize Side Effects?

Wegovy is specifically designed to be started at a very low dose and then gradually increased over time. This slow and steady increase, known as gradual titration, is a key strategy to help the body adjust to the medication. The main goal of this approach is to reduce the likelihood of side effects, especially common ones like nausea and other gastrointestinal symptoms, which can otherwise disrupt treatment. The Wegovy dosing schedule was updated in December 2025 to reflect the best practices for this gradual increase, as detailed in the Wegovy Dosing Guide 2026.

The Importance of Gradual Titration

Gradual titration is crucial because GLP-1 medications affect the digestive system and appetite. When the body is introduced to the medication slowly, it has more time to adapt to these changes. Starting with a low dose, such as 0.25mg, and increasing it incrementally over several weeks or months, allows the system to slowly get used to the drug's effects. This careful approach helps to prevent the sudden onset of severe side effects that might occur if a higher dose were started immediately.

For example, the initial doses are often very small, and the dose might only increase every four weeks. This extended period between dose increases gives the body ample time to stabilize before the next step. If a patient experiences significant side effects at a particular dose, their healthcare provider might recommend staying at that dose for a longer period or even reducing it temporarily before attempting another increase. This personalized approach is essential for successful and tolerable treatment.

Reducing Gastrointestinal Symptoms

Nausea and other gastrointestinal symptoms are the most common reasons people might consider stopping GLP-1 medications. By gradually increasing the dose, the body's digestive system can slowly adapt to the slower gastric emptying and other effects of the medication. This often means that while some mild nausea or discomfort might still occur, it is usually less severe and more manageable than if a full dose were given from the start.

Patients are often advised to eat smaller, more frequent meals and avoid fatty or very rich foods during the initial titration phase. Staying well-hydrated is also important. These dietary and lifestyle adjustments, combined with the slow dose escalation, work together to minimize the impact of gastrointestinal side effects. The goal is to make the treatment journey as comfortable as possible, allowing patients to continue with the medication and achieve their weight loss or diabetes management goals.

Adherence to the Dosing Schedule

Following the prescribed dosing schedule precisely is vital. Patients should not increase their dose more quickly than recommended by their healthcare provider, even if they feel they are tolerating the medication well. Rushing the titration process can lead to increased side effects and may make it harder to continue treatment. The schedule is designed based on clinical research to optimize both efficacy and tolerability.

If a dose is missed, patients should follow their doctor's specific instructions. Typically, they might be advised to take the missed dose as soon as they remember, as long as it's not too close to the next scheduled dose. However, they should never double up on doses. Consistent communication with the healthcare team about how the medication is being tolerated at each dose level is key to making informed decisions about adjustments. This ensures that the treatment remains safe and effective throughout its course.

Frequently Asked Questions

What are the most common initial side effects of Ozempic?

The most common initial side effects of Ozempic include abdominal pain or discomfort, loss of appetite, indigestion or heartburn, and reactions at the injection site. These symptoms are most likely to occur when first starting the medication or after a dose increase. For most people, these side effects tend to improve significantly after about 3 months of treatment.

Can Ozempic cause long-term vision problems?

Yes, Ozempic may cause long-term vision problems. It can worsen an eye condition called diabetic retinopathy, especially when blood sugar levels improve rapidly. In a 2-year study, 3% of Ozempic injection users experienced complications compared to 1.8% taking a placebo. Ozempic might also cause non-arteritic anterior ischemic optic neuropathy (NAION), a condition where the optic nerve doesn't get enough blood supply.

Is there a link between Ozempic and pancreatitis?

Pancreatitis, an inflammation of the pancreas, has been reported in some people taking Ozempic, but it is unclear if Ozempic directly causes it. In one 2-year study, 8 people taking injectable Ozempic experienced pancreatitis compared to 10 people taking a placebo. A more recent meta-analysis of about 35,000 patients found that semaglutide is not associated with a higher risk of pancreatitis compared to placebo.

What is 'Ozempic face' or 'Ozempic body'?

"Ozempic face" or "Ozempic body" are terms used to describe changes in body composition due to rapid weight loss from medications like Ozempic. Rapid fat loss can lead to a reduction in facial volume, making the face appear gaunt or older. Similarly, overall body fat reduction can alter a person's body shape, sometimes resulting in loose skin or a different distribution of fat and muscle.

What serious risks are associated with Wegovy?

Wegovy may cause serious side effects, including possible thyroid tumors, such as cancer. Studies in rodents showed that Wegovy and similar medicines caused thyroid tumors, including thyroid cancer. It is not known if Wegovy will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Patients should not use Wegovy if they or their family have a history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).